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A B S T R A C T
Complement component 5 (C5) is an essential factor of the defensive complement system in all vertebrates. We
report the characterization of C5 cDNA and protein from Atlantic salmon (Salmo salar), a teleost fish species of
high importance in aquaculture. The C5 cDNA cloned from liver is 5079 nucleotides long, whose translation
product has a molecular weight of 190 kDa, with the classical β-α orientation and motifs/sites for β-α cleavage
(678RPKR681) and cleavage by C5 convertases (R758). Mass spectrometric analysis show a single N-linked,
biantennary, complex glycan at N1125. Moreover, the N-linked glycan displays an unusual modification in the
form of acetylated sialic acid residues. Three anti-C5 antisera produced in mice using purified C5 worked in
immunohistochemical analyses of formalin fixed liver tissue. The purification method, whereby inactive and
activated (C5b) forms were isolated, opens for interesting studies on the complement function in fish, including
possible connection to stress, disease and glycosylation.
1. Introduction
The complement system is an important defense in all vertebrates,
and elements of the system evolution can be traced back to distant
ancestors (Palmer and Jiggins, 2015). A key factor of the vertebrate
complement system is the component 5 (C5). In mammals C5 is syn-
thesized as a single-chain pro-C5 precursor of approximately 190 kDa,
which post-translationally becomes glycosylated and undergo specific
cleavage immediately C-terminal of an internal arginine-rich linker
sequence. Hence the mature C5 consist of an alpha (C5α) and a beta
(C5β) chain which is covalently bound by disulfide bridges
(Chandrasekhar et al., 2012). C5 is one of more than 40 soluble proteins
and membrane-bound receptors and regulators that constitute the
complement system. Functionally it is a key component of a powerful
lytic cascade that can kill pathogens directly but it also plays an im-
portant role in host homeostasis and regulation of adaptive immunity
and inflammation (Merle et al., 2015). The complement cascade can be
activated via three different pathways, the alternative, the classical and
the lectin pathways, which all converge in establishing a C5 convertase
complex that cleaves the inactive C5 in plasma into bioactive C5a and
C5b subunits (Fig. 1). Following the proteolytic removal of C5a by C5
convertase, the soluble C5b cleavage product undergoes conformational
changes that create a short-lived site for binding of complement factor
C6, which is the first step in forming the lytic membrane-attack com-
plex (MAC). The final MAC consists of complements C6, C7, C8 and
multiple C9 (Köbis et al., 2015). In teleost fish, complement in serum,
mucus and even the cytosol of fertilized eggs (Wang et al., 2008) exhibit
pathogen killing capacity. Gram-negative bacteria are susceptible to
killing by the alternative (Sunyer and Tort, 1995) and classical (Boesen
et al., 1999) pathways, and non-pathogenic bacteria appear more sus-
ceptible than pathogenic (Ourth and Bachinski, 1987). Monogenean
ectoparasites (Buchmann, 1998; Harris et al., 1998), trematode en-
doparasites (Wood and Matthews, 1987) and protozoans (Forward and
Woo, 1996) have also been shown susceptible to fish complement
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killing.
Rainbow trout (Oncorhynchus mykiss) was the first species other
than human and mouse from which complement C5 was cloned and the
native protein purified (Franchini et al., 2001; Nonaka et al., 1981). In
common carp (Cyprinus carpio) two distinct full-length clones of C5, C5-
1 and C5-2, have been identified and shown to be 83% identical at the
amino acid level (Kato et al., 2003). Their data also suggested the
presence of multiple genes encoding the C5-type I and a single gene
encoding C5-type II, and possible functional divergence among the C5
types. Both trout and carp C5 factors were predicted to share basic
features with C5 from human and mice, including the two-chain (C5α
and C5β) structure of the mature protein, the existence of a C5a and the
lack of a thioester bond that distinguishes C5 from C3 and C4 in
mammals. These features were also demonstrated in C5 from a nurse
shark (Ginglymostoma cirratum), a cartilaginous fish (Graham et al.,
2009). Interestingly, the nurse shark C5 was more similar to mamma-
lian C5 than to teleost fish C5 at the amino acid level, suggesting an
evolutionary origin of this complement factor that predates the emer-
gence of sharks (Graham et al., 2009).
The aim of the present study was to clone and characterize the C5
transcript from Atlantic salmon (Salmo salar) liver tissue, and to purify
and characterize the native C5 protein from plasma. In addition, anti-
bodies were produced in mice against the purified protein.
2. Material and methods
2.1. Cloning of the complement C5 cDNA
RNA Ligase mediated Rapid amplification of cDNA ends (RLM-
RACE) technique was performed to facilitate cloning of the 5′ and 3′
ends of the S. salar C5 cDNA sequence using the FirstChoice RLM-RACE
kit (Ambion®) according to the manufacturer's instructions. Total RNA
was extracted using the RNeasy Plus Universal kit (Qiagen) from
∼50mg S. salar (harvested from Hellefoss cultivation station, Norway)
liver tissue grounded in liquid nitrogen. The C5 5′ cDNA end was am-
plified in a nested-PCR assay: 5′ RLM-RACE cDNA was amplified using
the 5′ RACE Outer Primer and the gene specific (GS) antisense primer
5′-GTGAGTAGACAGCAGTGTCAATAGCAG-3′, followed by a second
PCR using the 5′ RACE Inner Primer and the nested GS antisense primer
5′-GTATCGATGGCACCATGTCTGAGG-3′. 5′ RACE products were am-
plified in reactions containing 1U Phusion High-Fidelity DNA
Polymerase (Thermo Scientific®), 1X High-Fidelity (HF) buffer, 200 μM
dNTPs, and 0.5 μM sense and antisense primers, in a total reaction
volume of 50 μL. Thermal cycling was performed as follows: 98 °C for
30 s (s) followed by 40 cycles at 98 °C for 30 s, 60 °C for 20 s and 72 °C
for 90 s, and an final extension step at 72 °C for 5min (min). PCR
amplification of the cDNA corresponding to the 3′ end of the S. salar C5
transcript was performed using the 3′ RACE Outer Primer and GS sense
primer 5′- GTCAACCTACCCAGTGGCTCC-3′. The PCR condition was as
described for 5′ RACE. The GS primers were designed based on the O.
mykiss C5 CDS (GeneBank AF349001.1). 5′ and 3′ RACE PCR products
were cloned using the ZeroBlunt PCR cloning system (Invitrogen).
Plasmids containing 5′ and 3′ RACE PCR products were sequenced with
T7 and M13R primers using the ABI BigDye v.3.1 chemistry according
to the stepped elongation time protocol (Platt et al., 2007). Extension
products were precipitated with ethanol/sodium acetate and finally
sequenced by Capillary Electrophoresis using the 3130xL Genetic
Analyzer (Life Technologies). The sense and antisense primers 5′-ATG
AAACTCTTACTGCTTCTTTGT-3′ and 5′-TTAACAGCCTTCAAACAGAA
CAC-3′, respectively, were designed from RACE amplified reads to fa-
cilitate amplification of the full-length S. salar C5 cDNA. First, DNaseI-
treated total RNA (500 ng) were reverse-transcribed with 200 U Su-
perScript™ III reverse-transcriptase (RT) primed with 200 ng random
decamer primers in a 20 μL reaction volume according to the manu-
facturer's instructions. The full-length C5 cDNA was PCR amplified from
undiluted cDNA as described above using the following thermal PCR
profile: 98 °C for 30 s followed by 40 cycles at 98 °C for 10 s, 62 °C for
30 s and 72 °C for 80 s, and an final extension step at 72 °C for 5min.
Finally, the RT-PCR product was cloned and fully sequenced as de-
scribed above. CLC Genomic Workbench v.7 was used to analyze the
sequences.
2.2. Phylogenetic analysis
The amino acid sequences of C5, C4 and C3 from selected mam-
malian and fish species were sampled from GenBank. The sequences
were aligned using MAFFT (v.7.407) and the L-INS-I algorithm.
Phylogenetic analysis was performed using the maximum likelihood
method as implemented in CLC Genomic workbench 12 (https://www.
qiagenbioinformatics.com/). We used the WAG model of protein evo-
lution (Whelan and Goldman, 2001) with γ-distributed rate hetero-
geneity. Branch support was assessed by running 1000 bootstrap re-
plicates.
2.3. Blood samples for protein purification
Blood from wild Atlantic salmon (S. salar) was obtained from adult
males (3–10.7 kg), caught in a fish trap in the river Drammenselva,
Buskerud, Norway in December 2010 and 2011. To prevent blood
clotting, samples were collected in Vacutainers coated with ethylene-
diaminetetraacetic acid (EDTA) (BD Vacutainer 10mL K2EDTA,
367525). Two out of three samples were treated with 5mM EDTA and
Fig. 1. Putative schematic representation of the peptide processing from single-chain precursor of component 5 (C5), to mature inactive C5 (α + β), and to the
activated subunits C5a (ca. 9 kDa, gray) and C5b (α’ + β). Arrowheads indicate sites of enzymatic cleavage based on similarities with rainbow trout C5 (Franchini
et al., 2001). Also indicated (gray lines) are the relative positions of the two major inter- and intra-chain disulfide bridges in C5 molecules.
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50mM 6-aminocaproic acid (EACA) (Sigma-Aldrich, St. Louis, MO,
USA) at the time of collection to prevent complement protein activa-
tion. Following separation of blood plates by centrifugation, plasma
samples were stored at −80 °C.
2.4. Purification of the complement C5 protein
C5 protein was isolated from other plasma proteins by differential
polyethylene glycerol (PEG) precipitation followed by anion exchange
and size exclusion chromatography (SEC) (Franchini et al., 2001;
Nonaka et al., 1981). To thawed plasma (20mL), 50% PEG (Bioultra
PEG 3350; Sigma-Aldrich) was added to a 3.4% final concentration, the
sample incubated at 4 °C for 45min on a rocking table and the resulting
precipitates pelleted by centrifugation (10,000 g, 20min). The re-
covered supernatant was fortified with 50% PEG to 12.4% final con-
centration, incubated for 30min as above and centrifuged. The pelleted
protein (12.4% ppt.) was then solubilized in 5.0mL of 10mM sodium
phosphate pH 7.4, containing 10mM EDTA, 0.1 mM Pefabloc (Fluka;
76307) and 50mM EACA, and stored at −80 °C.
Prior to anion exchange chromatography, aliquots (1.0 mL) of so-
lubilized 12.4% ppt. Were applied to a HiTrap Desalting (5 mL) column
equilibrated in 10 mM sodium phosphate, pH 7.4 (buffer A). The
column void fractions from multiple injections were pooled and col-
lected. Desalted sample was applied to the Mono Q HR5/5-column
(1 mL/min) equilibrated in buffer A. The column was developed with a
salt gradient of 0–100% buffer B (i.e. buffer A + 0.7 M NaCl). Fractions
(1 mL) were collected and screened using ELISA with anti-trout C5
antibody for the presence of C5 (see section 2.4 for ELISA method).
Positive fractions were pooled and concentrated 3–5 times in dialysis
tubing (MWCO 6000, SpectraPor) embedded in solid PEG.
For size exclusion chromatography (SEC), aliquots (500 μL) of the
concentrated pool from anion exchange chromatography was applied to
a Superose 6 HR10/30 column. The column running buffer (1.0 mL/
min) was 25mM sodium phosphate pH 7.4, containing 150mM NaCl
and 5mM EDTA. C5-positive fractions (1 mL) by ELISA assay were
pooled and analyzed by SDS-PAGE (see section 2.5 for methodology).
All chromatography columns were the products of GE Healthcare
Biosciences AB (Uppsala, Sweden) and run on ÄKTA Pure chromato-
graphy system (GE Healthcare). Purified water (Direct-Q, Millipore,
Billerica, MA, USA) for buffers were filtrated through 0.22 μm prior to
use.
2.5. Immunoanalyses and SDS-PAGE of chromatography column fractions
Blood plasma samples, column fractions and purified C5 were
analyzed by ELISA, SDS-PAGE and Western blotting. Rabbit anti-trout
α-chain C5 IgG (primary antibody) was a kind gift from Dr. Oriol
Sunyer. Horseradish peroxidase (HRP)-conjugated donkey anti-rabbit
IgG was used as secondary antibody in both indirect ELISA and Western
blotting (BioRad Laboratories, Hercules, CA, USA).
Indirect ELISA was used for detecting salmon C5 reacting proteins in
column fractions. Fractions (50 μL), diluted either 1:50 or 1:100 in
0.05M sodium carbonate pH 9.6, were applied in parallel to microwell
plates (Nunc-Immuno Maxisorp). Blanks were added no sample. The
sample plates were incubated at room temperature for 90min, washed
in phosphate buffered saline containing 0.1% Tween (PBST), and
blocked for 90min using 2.5% bovine serum albumin (BSA) or 1% milk
(100 μL). Following incubation (45min) with the rabbit anti-trout C5
primary antibody (50 μL, 1:1500 in PBST) and 30min with the sec-
ondary antibody (HRP-conjugated donkey anti-rabbit IgG, 50 μL,
1:2000 in PBST), plates were developed with TMB substrate (1-Step
Ultra TMB-ELISA Substrate, Thermo-Fisher, 34029) and incubated for
10min in the dark. The HRP-reaction was stopped by adding 100 μL of
2M H2SO4 and optical density at 450 nm was recorded in a plate
reader.
Purified C5 fractions were separated by SDS-PAGE using 8–18%
gradient gels (GE Healthcare, 80-1255-53) and a Multiphor II
Electrophoresis Unit (GE Healthcare). Prior to loading on the gel, 5x
sample buffer (0.05M Tris pH 7.5, 1% SDS, 0.0001% Bromophenol
Blue) was added to the samples. For samples under reducing conditions,
dithiothreitol was added to a final 5mM and incubated for 10min at
95–99 °C. Precision Plus Protein Standard (BioRad, 1610373) was used
as molecular weight standard. Protein bands were visualized by
Coomassie Brilliant Blue (CBB). For Western blotting analysis, proteins
were blotted to nitrocellulose membranes (BioRad, 1620115) using the
method of Olsen and Wiker (1998). The membrane was blocked with
2.5% BSA in PBS, incubated overnight at 4 °C with rabbit anti-C5 an-
tisera (diluted 1:1000 in 0.25% BSA in PBS), then 60min with HRP-
conjugated donkey anti-rabbit IgG (diluted 1:1500 in 0.25% BSA/PBS),
and finally with DAB chromogen substrate (3′3 diaminobenzidine;
Sigma-Aldrich, D5637).
To perform in-gel protein digestion (see 2.6), SEC-purified samples
of C5 were separated by SDS-PAGE in 7.5% homogenous minigels
(1.5 mm thickness). Sample preparation in 5x sample buffer for reduced
and non-reduced conditions was as above, except β-mercaptoethanol
(final 0.5mM) was used in reduced samples. Gel loading of cooled
samples on separate gels (reduced/non-reduced) were 30 μL per well,
each with 6–7 μg protein. Gels were run for 100min at 100 V and
protein bands were visualized by CBB. Novex Sharp Broad Range pro-
tein standard (Invitrogen, Carlsbad, CA, USA) was used as size ladder.
Slices of stained protein bands from reduced and non-reduced samples
were carefully excised from the gel and subjected to protease digestion.
2.6. In-gel protein digestion of purified protein
In-gel protein digestion, including destaining of Coomassie-colored
gel slices, reduction, alkylation and extraction of peptides from 7.5%
preparative gel slices (6–7 μg protein/band) was performed as pre-
viously described (Anonsen et al., 2012). Peptides were generated with
the following proteases: (1) trypsin (Sigma-Aldrich, 1 μg) in trypsin
buffer (25mM NH4CO3) overnight at 37 °C, (2) AspN (Sigma-Aldrich,
0.3 μg) in AspN-buffer (50mM Tris(hydroksymetyl)aminomethane,
2.5 mM ZnSO4–7H2O, pH 8.0) at 25 °C, and (3) chymotrypsin (Sigma-
Aldrich, 1 μg) in chymotrypsin buffer (100mM Tris(hydroksymetyl)
aminometan 10mM CaCl2‧2H2O, pH 7.8) overnight at 25 °C. Digestion
products of trypsin, AspN and chymotrypsin were subsequently ana-
lyzed by a mass spectroscopy (MS) protocol.
2.7. Reverse phase LC–MS2 analysis of proteolytic peptides
Analyses of in-gel digested peptides were done by reverse phase
nanoflow liquid chromatography coupled to a nanoelectrospray LTQ
Orbitrap XL mass spectrometer utilizing a collision induced dissociation
(CID) fragmentation (RP nLC-ESI MS2). The RP nLC was performed as
previously described (Faste et al., 2016) except as follows: a Zorbax 300
SB-C18 5 μm pre-column (Agilent) were utilized. The nESI was achieved
by applying 1.2 KV between the 8 μm diameter emitter (PicoTip
emitter, New objectives) and the capillary entrance of the Orbitrap.
Peptide samples were analyzed with CID fragmentation method, ac-
quiring one Orbitrap survey scan in the mass range of m/z 200–2000
followed by MS2 of the ten most intense ions in the Orbitrap. The target
value in the LTQ-Orbitrap XL was 1,000,000 for survey scan at a re-
solution of 30,000 at m/z 400 using lock masses for recalibration to
improve the mass accuracy of precursor ions. Fragmentation in the LTQ
was performed by collision-induced dissociation with a target value of
5000 ions. Ion selection threshold was 500 counts. Selected sequenced
ions were dynamically excluded for 180 s.
2.8. MS data analysis
Raw LTQ Orbitrap XL data were analyzed with Proteome Discoverer
(v.1.4.7) and MaxQuant (v.1.4.1.2) utilizing the SEQUEST and
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Andromeda search engines, respectively. The database search was
performed by comparisons with an in-house generated database of
translated S. salar proteins (date downloaded 2017/07/18 NCBI) with
the predicted C5 sequence derived from the cloned cDNA generated in
this study. Trypsin, chymotrypsin or AspN were selected as enzymes for
samples treated with the respective enzymes allowing one missed
cleavage site. Tolerance of 10 ppm for the precursor ion in the first
search and 0.5 Da for the MS2 fragments was applied. In addition to
methionine oxidation, acetylation at protein N-terminus was allowed as
variable modifications. Cysteine carbamido methylation was set as
fixed modification. High confidence peptides set at False Discovery Rate
(FDR) < 0.01 and medium confidence peptide set at FDR<0.05.
2.9. Production and validation of polyclonal antibodies against salmon C5
Female BALB/c mice four weeks of age, were purchased from
Scanbur AS (94-CN-SIFE03W04W), brought to the experimental animal
facility and acclimated for two weeks prior to immunization. Three
mice each received five immunizations with the SEC-purified C5 pro-
tein. The primary immunization consisted of 16 μg C5 in 200 μL of a 1:1
(v/v) emulsion of PBS and Freund's complete adjuvant (Sigma–Aldrich,
F5881) administered by subcutaneous (SC) injection. Subsequently, the
mice received three SC boosts using 16 μg C5 in PBS and Freund's in-
complete adjuvant (Sigma–Aldrich, F5506), followed by an in-
traperitoneal injection of 16 μg C5 in 200 μL PBS five days prior to
sacrificing the mice. Blood samples of approximate 40 μL were drawn
from the thigh saphenous vein (Parasuraman et al., 2010) at every
immunization. At the termination, blood was collected through the
posterior vena cava (Parasuraman et al., 2010). Serum was prepared by
standard centrifugation.
The produced antisera were evaluated by the ELISA protocol de-
scribed earlier (section 2.5), except for the following: microwell plates
were coated with purified salmon C5 (1.0 μg/mL); primary antibodies
(mice pre-immune-sera and antisera) were diluted 1:200; the secondary
antibody (sheep anti-mouse IgG, GE Healthcare, NA931V) was diluted
1:2000. Western blotting analysis of the produced mouse anti-salmon-
C5 antisera was performed as described above using 8–18% gradient
SDS-PAGE (section 2.5) and using the antisera as primary antibodies in
a 1:1000 dilution. Samples of C5 were incubated for 10min at 70 °C in
sample buffer prior loading in the gel.
2.10. Immunohistochemistry
Sections from formalin fixed S. salar liver were incubated for 30min
in hot 0.01M citrate buffer pH 6.0 (heated by microwave oven) to
demask epitopes, followed by incubation for 10min in 3% H2O2 in
methanol to inhibit endogenous peroxidases. Sections were then
blocked with 5% BSA in TBS, followed by overnight incubation at 4 °C
with mice sera and antisera (1:4000 in 1% BSA in 0.1 M Tris buffer).
The slides were then incubated with Envision + System-HRP (Dako,
K4001) followed by staining with AEC + High Sensitivity Substrate
Chromogen (Dako, K3469) and counterstaining with Mayer's haema-
toxylin (AppliChem, A4840).
3. Results
3.1. Identification and sequencing of a full-length salmon C5 cDNA
RACE technique was used to obtain de novo cDNA sequence in-
formation to facilitate amplification and cloning of the full-length S.
salar C5 liver transcript. The 5′ and 3’ RACE products amplified from
salmon using gene specific primers (GSP) from O. mykiss yielded DNA
fragments of approximately 1.6 kb and 2.3 kb, respectively, both of
which was identified as the coding sequence (CDS) of C5 (data not
shown), confirming successful amplification of cDNA ends corre-
sponding to the salmon C5 transcript. To obtain the full-length C5
transcript sequence and to ensure that the RACE amplicons originated
from the same locus, the entire cDNA was amplified by RT-PCR as one
single fragment using GSPs designed based on the RACE products. The
resulting ∼5.1 kb fragment (Fig. 2A) was cloned and fully sequenced
(Appendix A). Alignment of the cDNA sequence to the published pre-
dicted genomic CDS sequence of salmon C5 (XM_014174798.1) show
99.9% (5075/5079) identity confirming the annotation of the genomic
DNA (Appendix B) and 99.8% (1688/1692) identity at the amino acid
level. The salmon C5 open reading frame is 5079 bp in length (Ap-
pendix A) and encodes a deduced C5 protein of 1692 amino acids
Fig. 2. S. salar C5 cDNA amplification and analysis. (A) The full-length C5 cDNA amplicon separated by 1% agarose gel electrophoresis. Lane M: 1000-bp molecular
DNA marker; 1: RT-PCR reaction for C5 (5079 bp); NC: non-template control. (B) Alignment of the deduced amino acid sequence (1692 aa) of the salmon (Ssa) C5
with the human (Hs) C5. Only part of the alignment is shown. The alignment was performed using the Clustal W algorithm. Blue letters represents absolute conserved
positions. The boxed sequence corresponds to the linker region between the α/β-chain junction. The arrow points to the convertase cleavage site (C5a/b) at aa 758.
The asterisk indicates the position of a N-linked glycosylation at aa 1125, and solid line the peptide segment identified by MS (see section 3.4 for details). Small
numbers above sequence refers to the alignment position. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version
of this article.)
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(Appendix C) with an estimated MW of 190.3 kDa. The post-transla-
tional processing signal, RPKR, that give rise to the mature β- and α-
chains are located at amino acid position 678–681 and the putative C5
convertase cleavage site at position 758 (Fig. 2B and Appendix C). A
pairwise alignment of salmon C5 and C3 shows that the cysteine (C)
and glutamine (Q) of the thiol-ester bond of C3 in the highly conserved
GCGEQ motif is missing in the C5 protein (Appendix D), which is a key
structural feature of this molecule (Lambris et al., 1998).
BLAST searches were carried out against the Atlantic salmon
genome on SalmoBase (https://salmobase.org), revealing that C5 is
transcribed from a single locus in the genome. To investigate the evo-
lutionary relationship of S. salar C5 to members of the C3/C4/C5
complement-component protein family, homologous protein sequences
were sampled from various fish species belonging to both the
Chondrichthyes (cartilage fish) and Osteichthyes (bony fish) classes, in
addition to two mammalian species (Fig. 3). As expected, S. salar C5
show close evolutionary relationship to trout (O. mykiss) C5 (Fig. 3A),
forming a monophyletic cluster with the C5 proteins of tilapia (Or-
eochromis niloticus), zebrafish (Danio rerio) and carp (C. carpio), and
separated from the C5 clade of the cartilaginous nurse shark (G.
cirratum), coelacanth (Latimeria chalumnae) and the mammalian species
(Homo sapiens andMus musculus). C4 (Fig. 3B) and C3 (Fig. 3C) proteins
cluster with similar topology into two separate monophylogenetic
lineages.
3.2. Purification and initial characterization of salmon C5
The isolation of C5 protein from plasma was carried out by PEG
precipitation followed by anion exchange and size exclusion chroma-
tography (SEC) (Franchini et al., 2001; Nonaka et al., 1981). To im-
prove binding to the MonoQ column, the re-suspended 12.4% PEG-
precipitate was desalted into the starting buffer prior to column
loading. The chromatography profile of the resuspended plasma pro-
teins from the MonoQ column is shown in Fig. 4A, where eluted frac-
tions were assayed for presence of C5 with ELISA using the anti-trout C5
antibody. Only a minor protein peak eluting at low salt concentration
(ca 12–13mS/cm) gave a significant ELISA response. ELISA-positive
peaks from several MonoQ separations were pooled and concentrated
and subjected to size exclusion chromatography where they resolved
into a major protein peak at 15.5mL. This peak corresponded to the
Fig. 3. Phylogeny of the C3/C4/C5 complement-component family of proteins. The tree was built using the maximum likelihood algorithm and the WAG protein
evolution model. The proteins cluster into three major phylogenetic groups corresponding to (A) C5, (B) C4 and (C) C3 sub-groups of proteins. The numbers within
the branch represents the bootstrap support for each partition. The GenBank accession numbers for the sequences used in the tree construction are: Trout
(Oncorhynchus mykiss) C5 (XP_021462359), C4 (NP_001117857), C3 (XP_021417252); Salmon C5 (this study), C4-like (XP_014069949.1), C3 (XP_014055640.1);
Shark (Ginglymostoma cirratum) C5 (ACH56749), C3-1 (AIN40971), C3-2 (AIN40972); Carp (Cyprinus carpio) C5-1 (BAC23057), C5-2 (BAC23058), C4-1 (BAB03284),
C3–S (BAA36621); Zebrafish (Danio rerio) C3 (XP_009293521.1), C5 (XP_001919226), C4–B (XP_005157429), Human (Homo sapiens) C3 (NP_000055), C4-A_1
(NP_009224), C5-2 (NP_001304092); Coelacanth (Latimeria chalumnae) C3 (XP_005994390), C5 (XP_014346298); Mouse (Mus musculus) C3 (NP_033908), C4
(AAC05279), C5 (NP_034536); Tilapia (Oreochromis niloticus) C5 (XP_019202498).
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stronger signal in anti-C5 ELISA evaluation (Fig. 4B). A minor signal,
corresponding to a lesser peak with higher molecular mass, was ob-
served. The molecular mass for the native C5 protein was estimated to
approximately 170 kDa by interpolation from calibration curve stan-
dards (Fig. 4B, inset).
Protein profiles from each step of the purification analyzed by non-
reducing SDS-PAGE, showed the gradual enrichment of a band between
150 and 250 kDa (Appendix Fig. A1). When SEC-purified C5 was ana-
lyzed under reducing conditions, the native protein split into two dis-
tinct fragments with molecular masses of ∼60 and 95–100 kDa
(Fig. 5A). The non-reduced protein and the reduced ∼100 kDa frag-
ment also gave discrete signals in a Western blot with antibody raised
against the α-chain of trout C5 while the lower fragment did not react
(Fig. 5B).
3.3. Mass spectrometric analysis confirms the identity of the salmon C5
protein
To identify and verify the amino acid sequence of the SEC-purified
salmon sample we performed RP nLC-ESI MS2 of in-gel digests of both
non-reduced and reduced purified C5 samples and searched the gen-
erated spectra against the salmon database containing the translated
cDNA C5 sequence. In the sample of the non-reduced band, the major
protein component identified in the sample was the C5 protein, with a
Proteome Discoverer score of 384.68 and 95 peptides identified from
the trypsin digest (Appendix Table A.1). Moreover, by analyzing pep-
tides from several SEC-purified samples we detected and identified
nearly the complete translated C5 cDNA amino acid sequence (94.4%,
Appendix Fig. A2, panel C). For AspN (Appendix Table A.2) and chy-
motrypsin (Appendix Table A.3), the Proteome Discoverer score and
number of peptides identified were 127.17/25 and 450.89/99, re-
spectively.
The MS analysis of samples generated from the upper (∼100 kDa)
and lower (∼60 kDa) bands from SDS-PAGE of reduced protein sample
(Fig. 5A) clearly showed that the main protein in both samples were
salmon C5 (Appendix Tables B.1-B.6) with the C5 peptides identified in
the upper and lower bands mainly originated from the α-chain and β-
chain, respectively (Appendix Fig. A2, panels A and B). However, MS
analysis also showed that complement factors C6 and C7 both were
notably present in the upper band (Appendix Table B.1-B.3).
Taken together, the MS data identified the major protein present in
the visible SDS-PAGE gel fragments from the SEC-purified reduced and
non-reduced samples (Fig. 5A) as the predicted salmon complement
factor C5 protein. Thus, the results also show that the mature salmon C5
protein separates under reducing conditions into two components
consistent with the predicted α-chain and β-chain structure.
3.4. The salmon C5 protein is glycosylated at a single site with an unusual
N-glycan
Interestingly, when inspecting the generated LC-MS2 spectra to
identify C5 peptides we detected several carbohydrate reporter ions in
the low mass areas indicating that salmon C5 was glycosylated. To
Fig. 4. Purification of complement C5 protein from salmon plasma. (A) Mono Q (1mL) chromatography of plasma proteins resuspended from a 12.4% PEG pre-
cipitate. Buffer A was 10mM Na-phosphate pH 7.4, at 1mL/min. The column was developed with gradient (hatched line) of 0.7M NaCl in buffer A; 0–5% B for 5mL,
5–30% for 15mL 30–60% for 2mL, 100% for 8 mL. Detection of C5 protein in fractions (1 mL) was assayed with ELISA using anti-trout C5 Ab (●). Horizontal bar
indicates pooled fractions. (B) Size-exclusion chromatography (SEC) of C5-positive fractions from the MonoQ column. The Superose6 column (24mL) was run at
1 mL/min in 25mM Na-phosphate pH 7.4, with 150mM NaCl and 5mM EDTA. The sample was 500 μL of a 5x concentrated pool obtained from multiple purifications
of same salmon plasma sample. Inset is of SEC calibration curve for estimation of relative molecular mass (RMM) of salmon C5. Horizontal bar indicate pooled
fractions.
Fig. 5. SDS-PAGE and Western blot analysis of SEC-purified salmon plasma C5
protein using SDS-PAGE (8–18% gradient) under reducing (Red.) and non-re-
ducing (Non-r.) conditions. Parallel analyses were stained with (A) Coomassie
Blue and (B) immunoblot probed with anti-trout C5α antibody (Dr. O. Sunyer).
Samples were pooled fractions from the Superose6 column (Fig. 4B). (For in-
terpretation of the references to color in this figure legend, the reader is referred
to the Web version of this article.)
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Fig. 6. Mass spectra of the N-linked glycopeptide 1111VDGDMLFNSIFWLINK1126 from S. salar C5. Underscore denotes the position of the glycan. MSMS of (A) MS2
spectrum of the precursor ion at m/z 1275.884 corresponding to the glycopeptide modified with the most abundant glycoform, the biantennary complex glycan with
a single terminal unacetylated sialic acid. (B) MS2 spectrum of the precursor ion at m/z 1289.890 corresponding to the glycopeptide modified with the biantennary
complex glycan with a single terminal monoacetylated sialic acid. (C) MS2 spectrum of the precursor ion at m/z 1303.893 corresponding to the glycopeptide
modified with the biantennary complex glycan with a single terminal diacetylated sialic acid. (D) The relative abundance (%) of all glycoforms detected on the
glycopeptide.
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investigate the nature of the glycosylation we subsequently extracted
the MS2 spectrum of the most abundant glycopeptide and investigated
the fragmentation pattern to solve both the glycan structure and the
peptide sequence. As seen in Fig. 6A the MS2 spectrum of the triply
charged precursor ion at m/z 1275.884 [M+3H+] (charge adjusted
mass 3825.638 Da [M + H+]) show multiple glycostructure related
ions in the high mass area as well as carbohydrate reporter ions in the
small mass area. Characterizing the glycan structure by investigating
the fragmentation pathway from the full-length glycan to the doubly
charged ion at m/z 956.48 [M+2H+] corresponding to the mass of the
unmodified peptide, led to the identification of the major glycoform
present on C5 corresponding to a biantennary complex N-linked glycan
with a single sialic acid residue (on either antennae).
Next, we characterized the microheterogeneity (i.e. the glycoform
variation) by identifying MS1 precursor masses corresponding to gain
or loss of carbohydrate units from the major glycoform and subse-
quently investigated the MS2 spectra to confirm glycosylation status.
Interestingly, several glycopeptide MS2 spectra showed evidence for
acetylation of the terminal sialic acid residues. As seen in Fig. 6B, the
MS2 spectrum of the triply charged precursor ion at m/z 1289.890
(charge adjusted mass of 3867.656 [M+H+] Da), glycan reporter ions
were detected corresponding to a biantennary complex N-linked glycan
seen in Fig. 6A with a single terminal sialic acid residue modified with a
single acetylation (42.011 Da). Similarly, the MS2 spectrum shown in
Fig. 6C of the triply charged precursor ion at m/z 1303.893 [M+3H+]
(charge adjusted mass of 3909.665 Da [M + H+]) corresponding to a
bi-antennary complex N-linked glycan with a single sialic acid residue
and two acetylation was detected. Subsequently, we identified all the
microheterogeneity (Appendix E) and quantified the relative abun-
dance of each glycoform (Fig. 6D). The ten identified glycoforms were
biantennary complex N-linked glycan, and most carried a terminal
sialic acid (siAs). Moreover, 53.3% of the total glycoforms identified
contained acetylated siAs demonstrating that salmon tends to decorate
the N-linked glycan on C5 with acetylation.
Finally, we identified the peptide sequence by investigating the MS2
spectrum of the most abundant glycoform (Fig. 6A), subtracting the
mass of the glycoform (1913.692 [M + H+] Da) from the observed
precursor ion mass at m/z 1276.22 [M+3H+] (charge adjusted to
3825.638 [M + H+] Da), to get the unmodified peptide mass (theo-
retical mass 1911.953 [M + H+] Da). Subsequently we compared the
unmodified peptide mass with theoretical trypsin generated C5 peptide
masses. Only the peptide 1111VDGDMLFNSIFWLINK1126 (theoretical
mass 1911.967 [M+H]) Da) matched the observed mass within the
accepted accuracy (< 10 ppm). Moreover, this peptide contained part
of the eukaryotic N-linked consensus sequon NK(T) at the C-terminal
end. No other N-linked glycosylation sequon was identified in the
translated C5 cDNA sequence and no other peptide sequence was
identified glycosylated in the LC-MS2 analysis, demonstrating that
salmon C5 is glycosylated with a complex biantennary N-linked glycan
predominantly carrying terminally acetylated sialic acids at a single
site, Asn1125 (highlighted with asterisk in Fig. 2B).
3.5. Production and evaluation of three mouse antisera against salmon C5
The three mice immunized with purified salmon C5 all developed
specific antibodies against C5 as judged by ELISA analysis. Between the
first immunization and the time where blood was terminally harvested,
the OD450 values in ELISA increased from a mean of 0.118 to a mean of
2.995 between the three mice. The SDS-PAGE (Fig. 7A) and Western
blotting analysis showed that the three antisera had very similar spe-
cificities (Fig. 7B–D). Against non-reduced C5 (lane 3), the antisera
showed strong binding to a ∼170 kDa band and a>250 kDa band. In
addition, there were minor binding to bands at ∼40, ∼85, ∼240
and> >250 kDa. Against reduced C5 (lane 2), the main binding was
to a 95–100 kDa band, but also to bands at∼60,∼125 and∼260 kDa.
No WB signals were observed using pre-immune serum (data not
shown). In immune-histochemical analysis, the pre-immune sera taken
from the three mice prior to immunization showed also no staining in
IHC analysis of liver. The corresponding antisera from the C5 im-
munized mice showed very similar IHC staining patterns, consisting of a
dispersed, low intensity staining of hepatocytes and strong staining of
single cells situated mainly around blood veins (Fig. 8A). Between the
antisera, a tendency to stain the rim of the sinusoids separating the
hepatic cords was most prominent in the antiserum from mouse 1
(Fig. 8B).
4. Discussion
Complement factor C5 is a pivotal component of the complement
system of vertebrates that connects early complement activation events
with downstream effector function and regulatory functions. After ac-
tivation via either the classical, the alternative or the lectin pathway,
the complement cascade of proteolytic activation converges in estab-
lishing particular C5 convertases that cleaves the inactive mature C5
into bioactive C5a and C5b subunits (Fig. 1). The C5b subunit is then
the starting point for a series of binding and conformational change
events, where binding of one complement factor (C6, C7, C8 and C9,
respectively) induces the formation of a binding site for the subsequent
complement factor. The smaller of the two C5 convertase cleavage
products, the anaphylatoxin C5a, has significant biological activities in
both mammals (Merle et al., 2015) and fish (Köbis et al., 2015; Li et al.,
2004; Li and Hu, 2016; Wu et al., 2014). The C5a exerts its function via
binding to a membrane-bound, specific C5a receptor.
The cloning of full-length salmon C5 mRNA revealed a 5079 nu-
cleotide long sequence that theoretically translates into a 1692 amino
acid protein. These sequence lengths are in complete compliance with
the predicted C5 genomic CDS (XM_014174798) and protein sequence
(XP_014030273.1). The cloned C5 sequence shows 99.9% and 99.8%
identity at the nucleotide and amino acid levels, respectively.
Compared to the salmonid fish species arctic char (Salvelinus alpinus)
and rainbow trout, the identities are 97.6 and 97.1% at the nucleotide
level, and 95.8 and 95.6% at the amino acid level, respectively. The
cloned salmon C5 cDNA included the canonical β-α cleavage site
(678RPKR681) which is identical to the site in rainbow trout (Franchini
et al., 2001), common carp (Kato et al., 2003) and nurse shark (Graham
et al., 2009), but different from the human RPRR sequence (Fig. 2B).
The MS data indicates a region for cleavage consistent with the cano-
nical site; two main sets of peptides cluster before and after the RPKR
sequence (Appendix Fig. A2), and no peptide spanning the cleavage site
is detected at high confidence. The C5 convertase cleavage site in our
clone is identical to that of rainbow trout, i.e. C-terminally of a con-
served Arginine (R) at aa 758. The salmon sequence surrounding the
cleavage site (756LARVE760) seems conserved among the salmonid
species (Arctic char, S. alpinus, XP_023858287 and rainbow trout,
XP_021462359) but is different from the two C5 isotypes identified in
common carp, being LSHSA for C5-1 and LSRSA for C5-2, respectively
(Kato et al., 2003).
Evolutionary analysis of the complement proteins shows that C3, C4
and C5 clustered into three separate distinct clades, as also reported in
previous studies (Kato et al., 2003, Nakao et al., 2003). The clade to-
pology conforms well with the diversification of fish orders represented,
namely by the Cypriniformes (carp and zebrafish), Cichliformes (ti-
lapia), Salmoniformes (trout, salmon), and the Orectolobiformes (nurse
shark). In the analysis we also included the lobed finned coelachant (L.
chalumnea), which is closer in evolution to the tetrapods (e.g. mouse
and human), but branching off later than the sharks. Not surprising, C3
and C5 of the two salmonids, brown trout and Atlantic salmon, show
close evolutionary relationship (Fig. 3A and C). This is not the case for
C4 were the C4-like protein in salmon diverges significantly from trout,
suggesting functional divergence of the C4 and C4-like proteins in these
two species.
Using a protocol combining fractional PEG-precipitation of protein
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and chromatographic principles (anion exchange, size exclusion chro-
matography), complement factor C5 was further purified from plasma
of Atlantic salmon. Similar protocols have resulted in but one C5 pro-
tein from trout (Nonaka et al., 1981) and from gilthead seabream
(Sunyer et al., 1997). The MW of ∼170 kDa of purified salmon C5 as
deduced from interpolating from SEC chromatograms and SDS-PAGE is
in accordance with these previous reports. However, the experimental
MW of the purified plasma protein is lower than 190.3 kDa estimated
from the predicted salmon C5 amino acid sequence (this study and
XP_014030273). The MWs, based on SDS-PAGE, of C5α and C5β was
estimated to ∼95–100 kDa and ∼60 kDa, respectively. For C5α this is
lower than the theoretically MW 114.3 kDa of salmon C5
(XP_014030273) and of human C5α (115 kDa). MS analysis (see below)
confirms the identity of C5α in this band. It is possible that the
95–100 kDa band observed in the gel (Fig. 4A) is composed of both the
full-length (α) and the activated (α′) C5b α-chain, the latter reduced by
app. 9 kDa (Fig. 1). For C5β, the theoretical MW (this study and
XP_014030273) is 76.0 kDa for salmon while human C5β has a MW of
75 kDa. For C5 protein isolated from rainbow trout, the MW's estimated
by SDS-PAGE were comparatively higher (194, 133 and 86 kDa for C5,
C5α and C5β, respectively) (Nonaka et al., 1981). These weights
however, differ relatively much from the theoretical MW's of rainbow
trout C5 forms (XP_021462359) which are very similar to those of
salmon C5. In Western blotting analysis using the rabbit antiserum
against rainbow trout C5α (kindly provided by O. Sunyer), the un-
reduced C5 band (170 kDa) and the reduced C5α band (95–100 kDa)
from salmon were recognized, confirming the identity of the purified
protein (Fig. 5). In addition, several low MW bands were faintly re-
cognized in the reduced gel as was a broad band at high MW
(>250 kDa) in the non-reduced. A similar pattern was seen for all the
three mouse anti-salmon C5 antisera produced here (Fig. 7B–D). The
very strong staining of the broad high MW band under non-reducing
conditions combined with its total absence under reducing conditions
could suggest the presence of protein aggregates or complexes con-
taining C5 in the purified salmon C5 preparation. Notably, under re-
ducing conditions, the dominating binding specificity of all the antisera
was directed against C5α and C5β.
Protein bands cut from SDS-PAGE gels run under reducing and non-
reducing conditions were subjected to enzymatic digestion with three
different proteases and subsequently analyzed by a MS protocol. These
analyses further affirmed the identity of the purified C5 protein and its
two chains, C5α and C5β. Peptides covering 94.4% of the deduced
protein sequence were identified when a multiple protease approach
was performed (Appendix Fig. A2). The data also show that the iden-
tified peptides from MS analysis of the upper 95–100 kDa band dom-
inantly map to the predicted C5α part of the C5 sequence, confirming
the nature of this band. Conversely, most peptides identified in MS
analysis of the lower 60 kDa band map to the predicted C5β. The fact
Fig. 7. SDS-PAGE and Western blot analysis of the three mouse anti-C5 antisera. (A) Coomassie Blue stained SDS-PAGE separation of purified C5 from Atlantic
salmon. Lane 1 pre-stained molecular weight marker, lane 2 reduced C5, lane 3 non-reduced C5, lane 4 pre-stained molecular weight marker. B-D: Three Western blot
replicas of the SDS-PAGE in A, stained with anti-salmon C5 antisera from three mice as primary antibody. (B) mouse anti-salmon C5 antiserum 1. (C) mouse anti-
salmon C5 antiserum 2. (D) mouse anti-salmon C5 antiserum 3. In each panel A–D, the arrowhead (lane 3) shows non-reduced C5α+C5β and the two arrows (lane 2)
show C5α and C5β, respectively.
Fig. 8. Immunohistochemical staining of comple-
ment C5 in salmon liver. (A) IHC using C5 antiserum
from mouse 2. Dispersed low-intensity staining of
hepatocytes. Distinct staining of individual cells
(black arrowheads) in proximity to vein (BV). (B)
IHC using C5 antiserum from mouse 1. Distinct
staining of single cells (black arrowheads) basally of
the endothelial layer of vein (BV). Well-defined
staining at the endothelial surface of sinusoids (black
arrow). Hepatocyte (red arrowhead), glycogen va-
cuole (red arrow). (For interpretation of the refer-
ences to color in this figure legend, the reader is re-
ferred to the Web version of this article.)
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that the identified peptides in the two bands does not map exclusively
to either C5α or C5β, highlights the somewhat incomplete separation of
proteins in SDS-PAGE protocols. Despite that C5 was the dominatingly
identified protein in the MS analysis of the three SDS-PAGE bands,
(Appendix Tables A.1–2 and B.1–6), other proteins were also identified.
This was particular evident for the C5α band, where both complement
factor C6 and C7 were notably abundant. The activated C5b subunit
(containing part of the C5α chain) binds to C6 to start the formation of
the lytic MAC, which also contains C7, C8 and multiple C9 (Köbis et al.,
2015). Some of the C5 protein purified in this study could actually
represent activated forms (C5b) bound to C6 and C7 factors.
Highly interesting, it was possible to identify and characterize an N-
linked glycosylation of salmon C5 protein based on LC-MS2 data. From
the MS2 spectrum of the most abundant glycoform, the mass of the
peptide without glycosylation was compared to the population of
peptides that would theoretically be produced by the enzymatic pro-
teolysis of the C5 sequence. A near perfect mass-match identified the
peptide 1111VDGDMLFNSIFWLINK1126 as the glycosylation-associated
sequence and Asn1125 as the amino acid with the glycosidic bond.
Further, the basic glycan structure of the N-linked carbohydrate was
shown to have a bi-antennary conformation, often with a sialic acid
residue on one or both of the antennae. The data further revealed that
variable acetylation of the sialic acid residues at the antennae led to a
glycoform microheterogeneity in the population of C5 molecules.
Overall, the identified glycoforms were characterized by biantennary,
complex N-linked glycans of which the majority carried a terminal
sialic acid that often (53.3%) were acetylated (Fig. 6D).
N-glycan acetylation is rare in mammalia (higher eukaryotes), but
has been previously described in Atlantic salmon (Jayo et al., 2012),
were also the acetylation of N-glycans has been proposed as a response
to stress (Liu et al., 2008). However, it remains to be investigated if the
presence of acetylated sialic acid on complement factor C5 indicates a
high level of stress as well. Assembly of the MAC is initiated when the
C5 convertase cleaves complement C5 into C5a and C5b. The role of
C5b is to recruit the pore protein C6 (Hadders et al., 2012), and the
C5b/C6 complex binds C7 thereby initiating formation of the MAC. Also
a glycoprotein, the C6 has multiple glycosylation sites, none of which
appear essential in the C6–C7 interface assembly (Aleshin et al., 2012).
Whether or not the identified N-linked glycosylation site in salmon C5
is of functional significance for MAC initiation, or serve other func-
tionalities needs to await further studies.
The identified N-linked glycosylation site in salmon C5 matches the
site Asn (N1125) and sequon, 1125NKT1127, predicted using the NetNGlyc
1.0. Server (CBS, Technical University of Denmark). In both rainbow
trout and arctic char, the T1127 is replaced by A1127, which likely results
in absence of N-linked glycosylation at N1125 or anywhere else in the C5
of these species as evaluated by NetNGlyc 1.0. Server prediction. In
contrast, the two C5 isoforms of common carp have two and three
potential N-linked glycosylation sites, nurse shark C5 three sites, and
human C5 four sites (Graham et al., 2009). According to our findings,
the N-linked glycosylation site of salmon C5 is situated in the C5α, as is
seen with the multiple sites of both nurse shark and human C5 (Graham
et al., 2009). In common carp, C5-1 have both its sites in C5β whereas
C5-2 have two sites in C5α and one in C5β. Seen in the light of the
overall conservation of complement C5 between species, at the amino
acid level as well as structural level, the variation in N-glycosylation is
interesting. In humans, most of the complement system components are
glycosylated and the individual component may exhibit a variable
number of glycoforms, erythrocyte CD59 having over 150 such forms
(Ritchie et al., 2002). The specific glycan structure is regulated by the
levels of glycosylation processing enzymes and since these differ be-
tween cells and tissues, the glycoform of a protein may vary with the
site of production. Predominantly synthesized in the liver, the human
C5 contain N-linked complex biantennary glycans with varying degree
of sialylation (Ritchie et al., 2002). Glycans have important functions
such as aiding protein folding, assembly and quality control and may
provide glycoproteins with recognition epitopes, protection against
proteases and restriction to non-specific protein-protein interactions.
In conclusion, we report the cloning and characterization of a full-
length C5 cDNA from Atlantic salmon liver as well as the purification
and characterization of native C5 protein from blood plasma of wild
salmon. To our knowledge, this is also the first in-depth analysis of the
glycosylation of a complement component from a fish species. The
highly interesting implication of identifying the unusual protein gly-
cosylation, is its potential use as a biomarker within the complement
cascade. Pending data from analysis of blood plasma obtained in con-
trolled experiments, we envision that response to stress and disease in
fish can be correlated to minute changes in C5/C5b-glycosylation. For
salmon aquaculture, such monitoring can be of economic importance.
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